Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6963
Source ID: NCT00605111
Associated Drug: Biphasic Insulin Aspart
Title: Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: biphasic insulin aspart
Outcome Measures: Primary: HbA1c, after 11 weeks of treatment | Secondary: The proportion of subjects achieving treatment target of HbA1c below 7%, at 11 and 24 weeks|8-point plasma glucose profiles, performed at 11 and 24 weeks|FPG, at 11 weeks and 24 weeks
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 193
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2003-12
Completion Date: 2004-10
Results First Posted:
Last Update Posted: 2017-01-11
Locations: Novo Nordisk Investigational Site, Blacktown, New South Wales, 2148, Australia|Novo Nordisk Investigational Site, Broadmeadow, New South Wales, 2292, Australia|Novo Nordisk Investigational Site, Fitzroy, 3065, Australia|Novo Nordisk Investigational Site, Garran, 2605, Australia|Novo Nordisk Investigational Site, Stones Corner, 4120, Australia|Novo Nordisk Investigational Site, Hong Kong Island, Hong Kong|Novo Nordisk Investigational Site, Shatin, New Territories, Hong Kong|Novo Nordisk Investigational Site, Cheras, 56000, Malaysia|Novo Nordisk Investigational Site, Georgetown, Penang, 10450, Malaysia|Novo Nordisk Investigational Site, Kota Bharu, Kelantan, 16150, Malaysia|Novo Nordisk Investigational Site, Cebu City, 6000, Philippines|Novo Nordisk Investigational Site, Quezon City, 1100, Philippines|Novo Nordisk Investigational Site, Singapore, 159964, Singapore|Novo Nordisk Investigational Site, Changhua, 500, Taiwan|Novo Nordisk Investigational Site, Kaoshiung, 807, Taiwan|Novo Nordisk Investigational Site, Bangkok, 10300, Thailand|Novo Nordisk Investigational Site, Bangkok, 10330, Thailand
URL: https://clinicaltrials.gov/show/NCT00605111

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress